Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
13F holders, Q1 2025
Institutional positions in Psyence Biomedical Ltd. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +1 vs. Q4 2024
- Shares held
- 5.71M
- −25.8K (−0.5%) vs. Q4 2024
- Total value
- $96.4K
- +$16.3K (+20.3%) vs. Q4 2024
- New holders
- 3
- 1 more added
- Sold out
- 2
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBMWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $121.6K |
| Q1 2026 | 19 | $96.6K |
| Q4 2025 | 21 | $101.1K |
| Q3 2025 | 23 | $142.4K |
| Q2 2025 | 23 | $123.8K |
| Q1 2025 | 23 | $96.4K |
| Q4 2024 | 22 | $80.2K |
| Q3 2024 | 23 | $79.2K |
| Q2 2024 | 28 | $71.9K |
| Q1 2024 | 30 | $499.9K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1,589 | $27 | 0.00% | +1,589 | New |
| Ancora Advisors, LLC | 5,000 | $84 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 20,923 | $354 | 0.00% | +20,923 | New |
| LPL Financial LLC | 29,345 | $496 | 0.00% | +29,345 | New |
| Virtu Financial LLC | 76,322 | $1.00K | 0.00% | +25,771+51.0% | Added |
| Mint Tower Capital Management B.V. | 50,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 76,843 | $1.30K | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 92,073 | $1.56K | 0.00% | 00.0% | Unchanged |
| Clear Street Derivatives LLC | 109,356 | $1.85K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 147,101 | $2.49K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 150,000 | $2.54K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 175,352 | $2.96K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 180,466 | $3.05K | 0.00% | −100−0.1% | Reduced |
| LMR Partners LLP | 200,000 | $3.38K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 200,000 | $3.38K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 200,117 | $3.38K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 247,857 | $4.20K | 0.00% | −25,000−9.2% | Reduced |
| Saba Capital Management, L.P. | 297,847 | $5.05K | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 468,500 | $7.92K | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 500,000 | $8.45K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 600,000 | $10.1K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 733,000 | $12.4K | 0.00% | 00.0% | Unchanged |
| Harraden Circle Investments, LLC | 1,150,000 | $19.4K | 0.01% | 00.0% | Unchanged |
| Walleye Trading LLC | 0 | $0 | 0.00% | −44,080−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −34,282−100.0% | Sold out |